View:
Download DOC
Download PDF
Download XLS
SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wilson George Laverne
(Last) (First) (Middle)
1800 W. LOOP SOUTH
SUITE 1500
(Street)
HOUSTON TX 77027
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2017 		3. Issuer Name and Ticker or Trading Symbol
Quanex Building Products CORP [ NX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 26,608 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) (1) 04/01/2021 Common Stock 15,000 20.27 D
Stock Options (Right to Buy) (2) 11/30/2021 Common Stock 17,600 15.08 D
Stock Options (Right to Buy) (3) 12/05/2022 Common Stock 14,900 21.11 D
Stock Options (Right to Buy) (4) 12/05/2023 Common Stock 7,300 17.63 D
Stock Options (Right to Buy) (5) 12/03/2024 Common Stock 6,300 20.28 D
Stock Options (Right to Buy) (6) 12/02/2025 Common Stock 14,400 19.31 D
Stock Options (Right to Buy) (7) 11/30/2026 Common Stock 17,100 19.45 D
Explanation of Responses:
1. The options became exercisable in three equal annual installments. The first installment became exercisable on April 1, 2012, and the next two installments became exercisable on April 1, 2013 and April 1, 2014.
2. The options became exercisable in three equal annual installments. The first installment became exercisable on November 30, 2012, and the next two installments became exercisable on November 30, 2013 and November 30, 2014.
3. The options became exercisable in three equal annual installments. The first installment became exercisable on December 5, 2013, and the next two installments became exercisable on December 5, 2014, and December 5, 2015.
4. The options became exercisable in three equal annual installments. The first installment became exercisable on December 5, 2014, and the next two installments became exercisable on December 5, 2015, and December 5, 2016.
5. The options will become exercisable in three equal annual installments. The first installment became exercisable on December 3, 2015, the second installment became exercisable on December 3, 2016, and the third installment becomes exercisable on December 3, 2017.
6. The options will become exercisable in three equal annual installments. The first installment became exercisable on December 2, 2016, and the next two installments become exercisable on December 2, 2017, and December 2, 2018.
7. The options will become exercisable in three equal annual installments. The first installment becomes exercisable on November 30, 2017, and the next two installments become exercisable on November 30, 2018 and November 30, 2019.
/s/ Paul B. Cornett, Power of Attorney 08/08/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Quanex Building Products Corporation
Power of Attorney

       The undersigned hereby constitutes and appoints Paul Cornett, Kevin
Delaney, and Brent Korb his true and lawful attorneys-in-fact and agents,
with full power of substitution and re-substitution, for him and in his
name, place and stead, in any and all capacities, to complete and sign
all Form ID's, Form 3s, Form 4s and Form 5s relating to equity securities
of Quanex Building Products Corporation and to file the same, with
all exhibits thereto or documents in connection therewith, with the
Securities and Exchange Commission, the New York Stock Exchange and
Quanex Building Products Corporation, granting to said attorney-in-fact
and agent, full power and authority to do and perform each and every
act and thing requisite and necessary to be done in and about the
premises, as fully to all intents and purposes as he might or could do
in person, hereby ratifying and confirming all that said attorney-in-fact
and agent, or substitute or substitutes, may lawfully do or cause to be
done by virtue hereof.

Executed this 26th day of  July, 2017.


/s/ George Wilson
George Wilson